Syncona - life sciences investor in truly innovative areas of healthcare

Who we are

Syncona is a leading healthcare company focused on investing in and building global leaders in life science. Our vision is to deliver transformational treatments to patients in truly innovative areas of healthcare while generating superior returns for shareholders.

Investors

Syncona is a FTSE250 business listed on the London Stock Exchange. Find the latest share price, announcements, presentations and events here.

Our portfolio

A selective portfolio of high quality healthcare businesses in truly innovative areas of science

Learn more

Transformational treatments

As we seek to build companies in truly innovative areas in healthcare, our ultimate goal is to deliver transformational treatments to patients, enabling them to continue enjoying their lives

Learn more

Achilles Therapeutics and the advent of immunotherapy

Syncona speaks to Achilles Therapeutics' clinical founder Charlie Swanton about his career, the advent of immunotherapy, and what he wants Achilles to achieve.